Loss-of-function mutation of serine racemase attenuates retinal ganglion cell loss in diabetic mice
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Experimental Eye Research
- Vol. 175, 90-97
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81371027)
- Zhejiang Province Natural Science Foundation (LY18H120003)
- National Natural Science Foundation of China for Youth (81600755)
- Wenzhou Medical University (QTJ10 001)
This publication has 42 references indexed in Scilit:
- NMDA receptor subunits have different roles in NMDA-induced neurotoxicity in the retinaMolecular Brain, 2013
- Serine racemase deletion abolishes light‐evoked NMDA receptor currents in retinal ganglion cellsThe Journal of Physiology, 2011
- Overexpression of serine racemase in retina and overproduction of D-serine in eyes of streptozotocin-induced diabetic retinopathyJournal of Neuroinflammation, 2011
- Serine Racemase Deletion Protects Against Cerebral Ischemia and ExcitotoxicityThe Journal of Neuroscience, 2010
- The glycine transporter GlyT1 controlsN‐methyl‐D‐aspartic acid receptor coagonist occupancy in the mouse retinaEuropean Journal of Neuroscience, 2009
- Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse modelHuman Molecular Genetics, 2009
- Neuritic dystrophy and neuronopathy in Akita (Ins2) diabetic mouse sympathetic gangliaExperimental Neurology, 2009
- Retinal ganglion cells in diabetesThe Journal of Physiology, 2008
- Serine racemase expression and d‐serine content are developmentally regulated in neuronal ganglion cells of the retinaJournal of Neurochemistry, 2007
- D‐Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosisThe EMBO Journal, 2007